EQUIMED
ActiveSummary
EQUIMED has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,230 and a net result of €39,691. Equity is shrinking by about 24% per year across the filed financial years. Its solvency ranks better than 6% of 1,590 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
01-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2023 to 2025net €39,691 ▲73.9%
Operating result €49,322, net result €39,691, both a record.
22-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 53 days late
2024
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.